Next Article in Journal
Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States
Next Article in Special Issue
Whose Responsibility Is It? Implementing Patient-Prioritized Healthcare System Change in Oncology
Previous Article in Journal
Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Guidelines

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer

1
Arthur Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada
2
Alberta Health Service, Calgary, AB T2S 3C3, Canada
3
Saskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada
4
Jewish General Hospital, Montreal, QC H3T 1E2, Canada
5
Department of Medical Oncology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada
6
London Health Sciences Centre, London, ON N6A 5W9, Canada
7
Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada
8
Sunnybrook Health Sciences, Toronto, ON M4N 3M5, Canada
9
The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada
10
McGill University Health Centre, Montreal, QC H4A 3J1, Canada
11
Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada
12
BC Cancer—Vancouver, Vancouver, BC V5Z 4E6, Canada
13
Juravinski Cancer Center, McMaster University, Hamilton, ON L8V 5C2, Canada
14
Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2024, 31(11), 7226-7243; https://doi.org/10.3390/curroncol31110533
Submission received: 28 September 2024 / Revised: 5 November 2024 / Accepted: 12 November 2024 / Published: 15 November 2024

Abstract

The accurate staging of breast cancer is fundamental for guiding treatment decisions and predicting patient outcomes. However, there can be considerable variation in routine clinical practice based on individual interpretation of guidelines and depending on the healthcare provider initially involved in working up patients newly diagnosed with breast cancer, ranging from primary care providers, triage nurses, surgeons, and/or oncologists. The optimal approach for clinical staging, particularly in asymptomatic patients presenting with intermediate-risk disease, remains a topic of dialogue among clinicians. Given this area of uncertainty, the Research Excellence, Active Leadership (REAL) Canadian Breast Cancer Alliance conducted a modified Delphi process to assess the level of agreement among Canadian expert clinicians on various staging recommendations. In total, 20 items were drafted covering staging based on biological status, the utilization of localization clips, both for the axilla during diagnosis and primary surgical site for margins and radiation therapy planning, and the use of advanced imaging for the investigation of distant metastases. Overall, the consensus threshold among all participants (i.e., ≥75% agreement) was reached in 20/20 items. Differences in clinical practice and recent findings from the literature are provided in the discussion. These consensus recommendations are meant to help standardize breast cancer staging practices in Canada, ensuring accurate diagnosis and optimal treatment planning.
Keywords: breast cancer; staging; recommendations; REAL Alliance breast cancer; staging; recommendations; REAL Alliance

Share and Cite

MDPI and ACS Style

Cao, J.Q.; Surgeoner, B.; Manna, M.; Boileau, J.-F.; Gelmon, K.A.; Brackstone, M.; Brezden-Masley, C.; Jerzak, K.J.; Prakash, I.; Sehdev, S.; et al. Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer. Curr. Oncol. 2024, 31, 7226-7243. https://doi.org/10.3390/curroncol31110533

AMA Style

Cao JQ, Surgeoner B, Manna M, Boileau J-F, Gelmon KA, Brackstone M, Brezden-Masley C, Jerzak KJ, Prakash I, Sehdev S, et al. Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer. Current Oncology. 2024; 31(11):7226-7243. https://doi.org/10.3390/curroncol31110533

Chicago/Turabian Style

Cao, Jeffrey Q., Brae Surgeoner, Mita Manna, Jean-François Boileau, Karen A. Gelmon, Muriel Brackstone, Christine Brezden-Masley, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, and et al. 2024. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer" Current Oncology 31, no. 11: 7226-7243. https://doi.org/10.3390/curroncol31110533

APA Style

Cao, J. Q., Surgeoner, B., Manna, M., Boileau, J.-F., Gelmon, K. A., Brackstone, M., Brezden-Masley, C., Jerzak, K. J., Prakash, I., Sehdev, S., Wong, S. M., Bouganim, N., Cescon, D. W., Chia, S., Dayes, I. S., Joy, A. A., & Henning, J.-W. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer. Current Oncology, 31(11), 7226-7243. https://doi.org/10.3390/curroncol31110533

Article Metrics

Back to TopTop